The extracellular calcium-sensing receptor (CaSR) monitors the systemic, extracellular, free ionized-calcium level ([Ca 21 ] o ) in organs involved in systemic [Ca 21 ] o homeostasis. However, CaSR is also expressed in the nervous system, where its role is unknown. We found large amounts of CaSR in perinatal mouse sympathetic neurons when their axons were innervating and branching extensively in their targets. Manipulating CaSR function in these neurons by varying [Ca 21 ] o , using CaSR agonists and antagonists, or expressing a dominant-negative CaSR markedly affected neurite growth in vitro. Sympathetic neurons lacking CaSR had smaller neurite arbors in vitro, and sympathetic innervation density was reduced in CaSR-deficient mice in vivo. Hippocampal pyramidal neurons, which also express CaSR, had smaller dendrites when transfected with dominant-negative CaSR in postnatal organotypic cultures. Our findings reveal a crucial role for CaSR in regulating the growth of neural processes in the peripheral and central nervous systems.
The growth, guidance and branching of neural processes in the developing nervous system are controlled by numerous locally acting and diffusible signaling proteins that bind specific receptors on the growing tips of these processes 1, 2 . Although changes in cytoplasmic Ca 2+ participate in transducing many of these growth and guidance signals, changes in the narrow physiological range of extracellular Ca 2+ have not been thought to be directly involved in regulating growth cone motility 3 . The level of extracellular Ca 2+ is monitored by CaSR, and in accordance with its crucial regulatory function in maintaining [Ca 2+ ] o in very narrow physiological limits 4 , it is conspicuously expressed in all structures and organs involved in systemic calcium homeostasis, such as the parathyroid glands, kidneys, bone and gut. It is also expressed in several other tissues and in multiple sites in the adult brain, including the subfornical organ, olfactory bulbs, striatum, cerebellum, basal ganglia and hippocampus, where its functions are unclear 5, 6 .
To investigate whether CaSR has a role in neuronal development, we screened for the expression of CaSR transcripts in several experimentally tractable populations of neurons in the peripheral nervous system of fetal mice. We found substantial CaSR expression in the superior cervical ganglion (SCG), a population of sympathetic neurons that is extensively used for investigating various aspects of neuronal development and is known to depend on the neurotrophin nerve growth factor (NGF) for survival and target field innervation in vivo [7] [8] [9] [10] . Here we demonstrate a previously unrecognized role for CaSR in enhancing sympathetic axon growth and branching at a stage of development when sympathetic neurons are innervating and branching extensively in their target fields, and also demonstrate a role for CaSR in regulating the growth and complexity of pyramidal dendrites in the postnatal hippocampus.
RESULTS

CaSR is expressed in developing sympathetic neurons
The developmental profile of CaSR mRNA expression in the SCG (Fig. 1a) revealed a relatively low level of expression at embryonic day 16 (E16) followed by a marked increase from E17 to a peak at E18. The peak was followed by a decrease in the immediate perinatal period and a slower decline to low levels over later postnatal stages. Western blot analysis revealed similar developmental changes in endogenous CaSR protein over the period E16 to postnatal day 1 (P1) ( Supplementary  Fig. 1 online) . To determine which SCG cells express CaSR, we localized CaSR protein in dissociated SCG cultures that were established at the peak of CaSR expression by immunocytochemistry using two different affinity-purified antibodies that recognize specific epitopes in the extracellular and cytoplasmic domains of CaSR protein, respectively. In double-labeled preparations in which neurons were positively identified with anti-b-III tubulin antibodies, both CaSR antibodies stained the cell bodies and entire neurite arbors of all neurons and also stained some of the non-neuronal cells ( Fig. 1b and Supplementary  Fig. 2 online).
[Ca 2+ ] o influences neurite growth from sympathetic neurons The high level of CaSR expression just before and after birth encompasses a period of development during which many sympathetic axons are branching extensively in their distal targets 7 . For this reason, we investigated whether modulating the function of CaSR at this stage of development would affect sympathetic neurite growth. We incubated low-density, dissociated cultures of E18 SCG neurons in defined, serum-free medium with several different concentrations of Ca 2+ that spanned the CaSR response range. We supplemented all cultures with NGF, as neurons at this stage of development require it in vivo 7 . Initial experiments revealed a very marked and consistent effect of [Ca 2+ ] o on neurite growth; however, to rule out any potential effects of lowering [Ca 2+ ] o on neuronal viability, we included a broad-spectrum, irreversible caspase inhibitor (Boc-D-FMK) in all experiments to ensure maximum neuronal survival in all experimental groups.
The sensitivity of CaSR to changes in [Ca 2+ ] o varies somewhat according to cell type and to the signaling events or physiological responses quantified in the range of 0.5-3 mM with the EC 50 or IC 50 ranging between B1 and B1.7 mM 11, 12 In the case of cultured E18 SCG neurons, quantification of total neurite length ( Fig. 2a) and Sholl analysis (Fig. 2b) , which provides a graphic representation of neurite length and branching with distance from the cell body 13 , revealed that neurite arbor size and complexity were affected by varying [Ca 2+ ] o in the range of 0.7-2.3 mM, concentrations at which CaSR is known to be either minimally (that is, 0.7 mM) or maximally (that is, 2.3 mM) active in native tissue 14 . The similar sizes of the neurite arbors of neurons grown with 1.4 mM and 2.3 mM [Ca 2+ ] o suggest that the influence of [Ca 2+ ] o on neurite growth is effectively saturating at these concentrations. The great majority of neurons in these cultures were surviving at 24 h when their neurite arbors were analyzed (B80% of those plated), and there was no significant difference in neuronal survival over the [Ca 2+ ] o range studied in these caspase inhibitortreated cultures (P 4 0.05; Supplementary Fig. 3 Fig. 4a ), but did not affect neurite growth from E18 CaSR-deficient SCG neurons (P 4 0.05; Supplementary  Fig. 5 online) , confirming its specificity. On the other hand, a CaSR Fig. 4b ). Neither the calcimimetic nor calcilytic affected neuronal survival in these experiments ( Supplementary Fig. 3 ).
The neurite arbors of E18 SCG neurons that were transfected with a plasmid expressing a CaSR with an arginine-to-glutamine substitution (R185Q) that exerts a dominant-negative effect on CaSR function 16 were significantly smaller than the neurite arbors of control-transfected neurons in medium containing 2.3 mM [Ca 2+ ] o (P o 0.001; Fig. 5a ).
To determine whether the reduction in neurite growth by the dominant-negative CaSR was a nonspecific effect of expressing this protein in neurons, we transfected P1 SCG neurons with the dominantnegative CaSR plasmid, as neurite growth from these neurons is unaffected by varying [Ca 2+ ] o over the sensitivity range of CaSR (Fig. 3b ). There were no significant differences in the overall neurite length and Sholl profiles of dominant-negative CaSR-transfected and control-transfected P1 SCG neurons grown in medium containing 2.3 mM [Ca 2+ ] o (P 4 0.05; Fig. 5b ), ruling out a nonspecific detrimental effect of this protein on neurite growth on E18 neurons. The lack of effect of the dominant-negative CaSR on neurite growth from P1 SCG neurons was most likely the result of the lack of functional levels of CaSR at this stage of development ( Fig. 1a and Supplementary Fig. 1 Fig. 5d ). Neither dominant-negative CaSR nor overexpression of wild-type CaSR affected neuronal survival in these experiments ( Supplementary Fig. 3) .
Finally, the neurite arbors of E18 SCG neurons from Casr À/À mice 17 were significantly smaller than those of wild-type littermates grown in medium containing 2.3 mM [Ca 2+ ] o (P o 0.001; Fig. 6a,b) . The length and Sholl plots of E18 SCG neurons from Casr +/À mice were consistently smaller than, although not significantly different from, those of wildtype littermates (P 4 0.05; Fig. 6a,b ), suggesting a possible small gene-dosage effect. Neurons from all three genotypes survived equally well in culture ( Supplementary  Fig. 3 ). Furthermore, E18 SCG neurons from Casr +/+ and Casr À/À mice showed identical survival dose responses to NGF (Supplementary Fig. 6 online), indicating that CaSR is not involved in promoting SCG neuron survival. Taken together, these findings demonstrate that activation of CaSR by [Ca 2+ ] o enhances neurite growth, but not survival, from cultured SCG neurons during a narrow developmental window in the immediate perinatal period. Because the neurites in short-term SCG cultures, such as those used in our study, are exclusively axons rather than dendrites 18 , it is reasonable to assume that CaSR positively regulates axonal growth and branching during this period of development.
CaSR-deficient mice have decreased sympathetic innervation
To determine whether our in vitro demonstration of the involvement of CaSR in regulating axonal growth from developing sympathetic neurons is physiologically relevant for sympathetic innervation in vivo, we compared the sympathetic innervation density of the iris at P1 in wild-type mice and littermates that were homozygous and heterozygous for a null mutation in the Casr gene. dense innervation from the SCG by axons that can be easily identified and quantified by immunostaining for tyrosine hydroxylase. Representative fields of tyrosine hydroxylase-expressing sympathetic fibers of Casr +/+ , Casr +/À and Casr À/À iris showed a clear decrease in innervation density in Casr À/À mice compared with Casr +/+ mice (Fig. 6c) . Quantification of tyrosine hydroxylase staining in multiple sections from all three genotypes revealed a highly significant reduction in the sympathetic innervation density of Casr À/À mice and a small, but statistically insignificant, reduction in Casr +/À mice compared with the Casr +/+ mice (P o 0.001; Fig. 6d) .
To exclude the possibility that decreased tyrosine hydroxylase immunofluorescence in the iris of Casr À/À mice was not simply a result of down-regulation of tyrosine hydroxylase expression in the innervating neurons, we quantified tyrosine hydroxylase mRNA levels and immunofluorescence in the SCG of these mice and their wild-type littermates. These studies found no significant differences in the levels of either tyrosine hydroxylase mRNA (P 4 0.05; Fig. 6e ) or tyrosine hydroxylase immunofluorescence intensity ( Supplementary  Fig. 7 online) .
Reduced sympathetic innervation density could not only be the result of defective axonal growth and branching, but also from a decrease in the size of the innervating population of neurons. To investigate whether excessive loss of SCG neurons in Casr À/À mice contributed to the innervation defect, we counted the number of neurons in the SCG of Casr +/+ and Casr À/À mice at P1 and found no significant differences (P 40.05; Fig. 6f ). There were also no significant differences in the nuclear diameter of SCG neurons or in the volume of the SCG (P 4 0.05; Supplementary Fig. 7 ) between genotypes. Taken together, these results demonstrate that CaSR has a crucial role in establishing appropriate sympathetic target innervation density, but is not required for the survival of developing sympathetic neurons in vivo.
CaSR regulates dendritic growth in the hippocampus Our discovery that CaSR has a crucial role in regulating axonal growth from sympathetic neurons at a stage in development when they express high levels of CaSR raised the possibility that CaSR may have a similar role in regulating the growth of neural processes from other neurons that express this receptor. To test this possibility, we studied the consequences of disrupting CaSR function in hippocampal pyramidal neurons, as these neurons express increasing levels of CaSR in rats several days after birth 11, 19 . Dendrites start growing from hippocampal pyramidal neurons during late fetal development and become larger and increasingly elaborate during subsequent postnatal development 20 .
We first confirmed the expression of CaSR in mouse hippocampal neurons at P4, a stage at which organotypic brain-slice cultures can be efficiently established and the pyramidal neurons ballistically transfected 21 Fig. 8 online) and immunocytochemistry revealed that CaSR is expressed by both neurons and glial cells in dissociated cultures established from P4 mouse hippocampus ( Supplementary  Fig. 8 ). We transfected pyramidal neurons with the dominant-negative CaSR plasmid or an empty control plasmid by firing gold microcarriers coated with these plasmids into organotypic slice cultures 21 . Dominant-negative CaSR-expressing and control-transfected neurons were recognized by coating the microcarriers with plasmids that expressed red fluorescent protein (RFP) or yellow fluorescent protein (YFP), respectively. We scanned pyramidal neurons in each labeled group in the CA2 and CA3 regions of the hippocampus 48 h after transfection and analyzed the resulting Z stack images of the dendritic trees 21 . The dendritic arbors of dominant-negative CaSR expressing neurons were significantly shorter and less branched than those of controltransfected neurons (P o 0.001; Fig. 7a ). Overexpressing wild-type CaSR in these neurons did not increase the size and complexity of the dendritic arbors (Fig. 7b) , indicating that the endogenous level of CaSR in these neurons, similar to that in E18 SCG neurons, is not limiting. The dendritic arbors of representative dominant-negative CaSR-transfected and control-transfected neurons are illustrated in Figure 7c . These findings suggest that CaSR has a role in regulating the growth and complexity of the dendritic arbors of hippocampal pyramidal neurons in postnatal mice.
. Real-time PCR (RT-PCR) demonstrated that the hippocampus contained transcripts encoding full-length CaSR at this stage (Supplementary
DISCUSSION
Our study has demonstrated a previously unknown function for CaSR in the regulation of the growth of neural processes in the peripheral and central nervous system. Activating CaSR in late fetal sympathetic neurons with either elevated [Ca 2+ ] o or a calcimimetic in the presence of lower [Ca 2+ ] o enhances axonal growth in culture, whereas a calcilytic, dominant-negative CaSR or the deletion of CaSR eliminate the effects of elevated [Ca 2+ ] o on axonal growth. The influence of CaSR on sympathetic axon growth is restricted to the immediate perinatal period of development when the expression of CaSR in sympathetic neurons is high and when sympathetic axons are growing and branching extensively in their target fields 8 . Our finding that the sympathetic innervation density of the iris was significantly lower in CaSR-deficient newborn mice compared with wild-type littermates demonstrates that the effect of CaSR on axonal growth from sympathetic neurons is physiologically relevant for the establishment of normal sympathetic innervation density in vivo. Although CaSR enhances sympathetic axonal growth and target field innervation, it is not required for sympathetic neuron survival either in vitro or in vivo.
The influence of CaSR on sympathetic axon growth declines rapidly following birth, with a decrease in CaSR expression in sympathetic neurons. It is known that the fetus is relatively hypercalcemic compared with the adult, with a [Ca 2+ ] o of around 1.7 mM at late stages of gestation 22 . Because the neurite growth-promoting effect of [Ca 2+ ] o reaches saturation around 1.4 mM (Fig. 2) , our findings suggest that the ambient [Ca 2+ ] o to which sympathetic neurons are exposed in utero before birth constitutively stimulates axonal growth via CaSR. This implies that the effect of CaSR on axonal growth in utero is controlled primarily by its level of expression rather than by fluctuations in [Ca 2+ ] o . Our finding that overexpressing CaSR in E18 SCG neurons does not enhance neurite growth in medium containing a maximally activating level of [Ca 2+ ] o , but does confer responsiveness to elevated [Ca 2+ ] o in P1 SCG neurons, implies that CaSR expression falls from a maximally effective level for promoting neurite growth at E18 to a functionally ineffective level by the end of the first postnatal day. This developmental decrease in CaSR expression, together with the abrupt decrease in [Ca 2+ ] o that follows parturition 22 , effectively curtail the influence of CaSR on sympathetic axon growth in vivo. Taken together, our findings demonstrate that the constitutive activation of CaSR in utero enhances axon growth late in gestation in sympathetic neurons of the peripheral nervous system, and that this is crucial for the establishment of appropriate target innervation.
Our demonstration that dominant-negative CaSR markedly reduced the size and complexity of hippocampal pyramidal dendritic arbors in the intact neuropil of postnatal organotypic slice cultures shows that CaSR also enhances dendritic growth in the developing central nervous system. In the developing rat, cerebrospinal fluid and brain interstitial 26, 27 .
METHODS
RT-PCR quantification of mRNA levels. Extracted total RNA (RNeasy Mini extraction kit, Qiagen) was reverse transcribed for 1 h at 37 1C with StrataScript reverse transcriptase (Stratagene) in a 40-ml reaction with 5 mM dNTPs (Stratagene) and 10 mM random hexamers (Amersham). For quantification of CaSR and tyrosine hydroxylase mRNA levels, 3 ml of each reaction product was amplified in a 25-ml reaction using the Brilliant QPCR kit (Stratagene). We used 5¢-ACC TGC TTA CCC GGA AGA GGG CTT T-3¢ and 5¢-AAT TCA GGT GCC GTA GGT GTT TCA G-3¢ as CaSR primers, and 5¢-AAG GAA AGT GTC AGA GTT G-3¢ and 5¢-ACC CTG CTT GTA TTG GAA-3¢ as tyrosine hydroxylase primers. Data were normalized to GAPDH mRNA. We used 5¢-TCC CAC TCT TCC ACC TTC-3¢ and 5¢-CTG TAG CCG TAT TCA TTG TC-3¢ as GADPH primers. PCR was carried out with the Mx3000P (Stratagene) with 40 cycles of 95 1C for 30 s, 58 1C (CaSR), 55 1C (tyrosine hydroxylase) or 51 1C (GAPDH) for 1 min, and 72 1C for 30 s. These cycles were followed by 95 1C for 1 min, 65 1C for 30 s and 95 1C for 30 s. A melting curve confirmed that the SYBR green signal corresponded to a unique and specific amplicon. Standard curves were generated for every RT-PCR run by using serial threefold dilutions of reverse-transcribed RNA extracted from E13 embryos.
RT-PCR detection of full-length and splice variant CaSR was carried out with the forward primer 5¢-ACC TGC TTA CCC GGA AGA GGG CTT T-3¢ and the reverse primer 5¢-GCA CAA AGG CGG TCA GGA AAA TGC C-3¢. b-actin cDNA was also amplified as a control using the forward primer 5¢-TCC TAG CAC CAT GAA GAT C-3¢ and the reverse primer 5¢-AAA CGC AGC TCA GTA ACA G-3¢. PCR was carried out for 35 cycles of 94 1C for 30 s, 56 1C (CaSR), 50 1C (b-actin) for 30 s, and 72 1C for 1 min. The PCR reaction was terminated with a final extension at 72 1C for 8 min.
Immunoblotting. We lysed 20-25 ganglia per age in RIPA buffer, and insoluble debris was removed by centrifugation. Protein concentration was determined by the BSA Protein Assay Kit (Pierce) and 18 mg of protein per lane were resolved on 10% denaturing polyacrylamide gels. Samples were transferred to PVDF membranes using the Bio-Rad TransBlot (Bio-Rad). Membranes were blocked with 5% dried milk in PBS with 0.1% Tween-20. CaSR-immunoreactive bands were detected using an N-terminus polyclonal antibody to CaSR (1:5,000; Imgenex) 28 , and an HRP-conjugated secondary antibody to rabbit (1:2,000; Promega) and ECL-plus (Amersham).
Neuron cultures. Dissociated cultures of SCG neurons were set up from CD-1 mice or from E18 Casr +/+ , Casr +/À and Casr À/À C57Bl/6 mice 17 , and were grown on polyornithine/laminin-coated 35-mm tissue culture dishes in defined medium 28 supplemented with 0.4 ng ml -1 NGF and 100 mM Boc-D-FMK. Organotypic slice cultures of P4 CD1 mouse hippocampi 21 were grown in neurobasal medium (Gibco) supplemented with 2% B-27 and 2% heatinactivated horse serum. [Ca 2+ ] o in the tissue culture medium was measured using a radiometer 125 and adjusted to the required level using EGTA or CaCl 2 .
Ballistic transfection. Ballistic transfection of dissociated neuron cultures and organotypic brain-slice cultures was carried out as previously described 21 . Gold particles were coated with either pYFP or pRFP (Clontech), together with human parathyroid CaSR-pcDNA3.1, dominant-negative CaSR (DN CaSRpcDNA3.1) or pcDNA3.1 control plasmid. DN CaSR-pcDNA3.1 expressed the R185Q-CaSR that has been described and characterized previously 15 . For organotypic brain-slice culture transfections, a Bcl-X L expression plasmid was adsorbed to all gold particles to ensure similar neuronal survival in both experimental and control-transfected neurons. For dissociated cultures, the neurons were transfected 3 h after plating.
Quantification of neuronal survival. The survival of transfected neurons in dissociated cultures was quantified by counting the numbers of transfected YFP-labeled neurons 12 h after transfection and again at 48 h, and then expressing the number surviving at 48 h as a percentage of the initial number of YFP-labeled neurons. The area counted was defined by the area in which the gold particles could be seen to be embedded in the bottom of the culture dish. Survival in nontransfected cultures was quantified by counting the number of neurons in a 12 Â 12-mm grid in the center of the dish 3 h after plating and again at 24 h, and then expressing the number of neurons surviving at 24 h as a percentage of the initial number of neurons counted. Duplicate cultures were set up for all conditions, and the data were compiled from three or more separate experiments.
Analysis of neuritic arbors. The neurite arbors of transfected neurons in dissociated cultures or organotypic cultures were visualized by expression of either YFP or RFP. In nontransfection experiments, neurite arbors were labeled with the fluorescent dye calcein-AM (Invitrogen) at the end of the experiment. For every condition in each experiment, images of at least 100 neurons were digitally acquired using an Axioplan Zeiss laser-scanning confocal microscope, and neuritic arbors were traced using the LSM510 software (Zeiss). These traces were used to ascertain total neurite length and the number of branch points. Fast-Sholl analysis was also carried out on these traces as previously described 29 . Pair-wise comparisons were made using Student's t-test (twotailed). For multiple comparisons ANOVA was carried out followed by Tukey's post hoc test.
Immunocytochemistry. Cultured SCG or hippocampal pyramidal neurons were fixed in ice-cold methanol for 10 min and were washed twice in phosphate-buffered-saline (PBS) before blocking nonspecific binding and permeablizing the cells with 5% BSA and 0.02% Triton X-100 in PBS for 1 h at 18-22 1C. The cells were incubated with primary antibody in 1% BSA at 4 1C for approximately 18 h. The primary antibodies used were a monoclonal antibody to b-III tubulin (1:1,000, Promega), a polyclonal antibody to CaSR that was raised to the CaSR N terminus 30 (1:200, Imgenex) and a polyclonal antibody to CaSR that was raised to a carboxy-terminal sequence of rat CaSR 31 (gift from D. Shoback, University of California, 1:100). After three washes, the cells were incubated with the appropriate secondary antibody, either Alexa 594-conjugated antibody to mouse IgG (Invitrogen) or Alexa 488-conjugated antibody to rabbit IgG (Invitrogen), diluted 1:500 in PBS containing 1% BSA and 0.02% Triton X-100 for 90 min at 18-22 1C. Negative controls (no primary antibody) were set up in all cases.
Immunohistochemistry. The eyes of Casr +/+ , Casr +/À and Casr À/À littermates were fixed in formalin (BDH) overnight at 4 1C and were cryoprotected in 25% sucrose in PBS overnight at 4 1C before being frozen. We cut 15-mm serial sections at right angles to the visual axis. The sections were mounted onto polylysine-coated slides (BDH) and were blocked with 10% normal goat serum containing 0.1% Triton X-100 in PBS for 1 h at 18-22 1C. After incubation for 18 h at 4 1C with a rabbit polyclonal antibody to tyrosine hydroxylase (Chemicon) diluted 1:200 in PBS with 2% normal goat serum, the sections were washed three times in PBS before being incubated with an Alexa 594-conjugated goat secondary antibody to rabbit (Alexa-Fluor, Invitrogen, 1:500). All sections were counterstained with DAPI (Chemicon). Four images were digitally acquired from sections passing through the iris, each one from a different quadrant of the iris. The outline of the iris in these images was traced using Adobe Photoshop 7. The total iris area and the area containing tyrosine hydroxylase-positive fibers were estimated by automated pixel counts, and the ratio of tyrosine hydroxylase-positive area to total iris area was calculated as a percentage. Six eyes for each genotype were sectioned and analyzed before the genotypes were ascertained to avoid any sampling bias. For tyrosine hydroxylase immunohistochemistry of SCG, P1 Casr +/+ and Casr À/À heads were fixed in formalin (BDH) for 3 d at 4 1C before dehydration and wax embedding. We stained 8-mm microtome sections for tyrosine hydroxylase as described above, and digital images were acquired using identical settings for both genotypes.
Quantification of neuronal number in the SCG. Estimates of the numbers of neurons in the SCG of P1 Casr +/+ and Casr À/À pups were carried out using stereology on serial sections as previously described 32 .
Casr mutant mice. The Casr mutant mice used have a deletion of exon 5 (ref. 17) . Because these mice express a truncated receptor that might have some activity 33 , we carried out RT-PCR using primers that amplify both the fulllength and splice-variant transcripts to ascertain whether this splice variant is expressed in SCG neurons in wild-type and/or knockout mice. As expected, both transcripts were amplified from the positive control tissue (kidney of Casr +/À mice 33 ), and the full-length transcript was amplified from the SCG of P1 Casr +/+ and Casr +/À mice. However, transcripts for the splice variant were not detectable in the SCG of P1 Casr +/+ , Casr +/À or Casr À/À mice (Supplementary Fig. 9 online) . This indicates that the truncated, in-frame CaSR receptor was not having an impact on our results.
Note: Supplementary information is available on the Nature Neuroscience website.
